Natural ginsenosides often exhibit low bioavailability and weak therapeutic efficacy for metabolic and inflammatory disorders. Enhancing the chemical structure addresses the inherent performance bottleneck of native compounds in treating obesity and inflammation.

Insufficient biological response to physiological stressors and exhaustion. Improving systemic recovery and defense mechanisms addresses the physical limitations of burnout and immunodeficiency.